4.9.8.2Vertical
LTC & Institutional Pharmacies
Pharmacies dispensing medications to nursing homes and institutions.
Market snapshot
These figures describe Retail & Specialty Pharmacy (4.9.8), the segment that LTC & Institutional Pharmacies sits within — not LTC & Institutional Pharmacies on its own.
- Market size
- ~$544B
- Companies
- ~42,700
FragmentationConsolidatedEstimate
U.S. Census Bureau 2022 Economic Census, NAICS 456110 (Pharmacies & Drug Retailers). Growth not shown — the 2022 retail reclassification (from 446110) makes 2017–22 comparison unreliable; revenue is largely drug pass-through.
Business model & economics
Revenue model
Drug-dispensing revenue (largely pass-through) plus front-of-store
Key economics
- Recurring revenue
- High
- EBITDA margin
- Thin dispensing margins, PBM-squeezed
- Capex intensity
- Moderate
recurring prescription refills
Characteristics
- Consolidated but financially stressed retail channel.
- Specialty pharmacy the high-growth piece.
- New entrants reshaping distribution; thin PBM-squeezed margins.
M&A deal context
Deal activityModerate
Who’s acquiring
- Pharmacy chains & strategics
- Specialty-pharmacy consolidators
- Mail-order & new-entrant platforms
What’s driving deals
- Specialty-pharmacy growth and acquisition.
- Channel disruption from mail order and new entrants.
- Reimbursement pressure and store rationalization.
Find LTC & Institutional Pharmacies acquisition targets
Search Acquisera’s index for companies classified under LTC & Institutional Pharmacies (4.9.8.2) and build a targeted deal pipeline.
Search companies